I asked the CEO some time back if a BP could go straight into P2 cancer trials if one was to buy out PAA at some time in the future. Response below.
Great question. There is a chance they would but BP is more likely to take a conservative approach and conduct a Phase1b study given funding is not normally an issue for BP. Cancer studies and even studies in other neurodegenerative disease are moving more towards adaptive designs with go - no go interim endpoints. For example we are currently investigating the best study design for our next MND study and that will likely be a phase2/3 adaptive design.Thanks for your support.Michael
Cheers
- Forums
- ASX - By Stock
- The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
I asked the CEO some time back if a BP could go straight into P2...
-
- There are more pages in this discussion • 342 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $89.95M |
Open | High | Low | Value | Volume |
18.5¢ | 19.0¢ | 18.5¢ | $111.6K | 601.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 169572 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 613756 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 169572 | 0.185 |
8 | 54129 | 0.180 |
4 | 344819 | 0.175 |
8 | 565800 | 0.170 |
4 | 385807 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 613756 | 10 |
0.195 | 605600 | 8 |
0.200 | 231600 | 9 |
0.205 | 221875 | 2 |
0.215 | 178520 | 3 |
Last trade - 15.46pm 30/08/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online